CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-13 | MYERS STEVEN S Director | Grant or award | +18,292 | $3.28 | $60K | 75,319 |
| 2020-01-08 | LOSORDO DOUGLAS W See Remarks | Shares withheld for taxes | −1,821 | $2.83 | $5K | 116,197 |
| 2020-01-08 | Talamo Joseph SVP and CFO | Shares withheld for taxes | −1,821 | $2.83 | $5K | 45,435 |
| 2020-01-08 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −4,522 | $2.83 | $13K | 153,010 |
| 2019-01-14 | Schwalm Cynthia Director | Grant or award | +12,121 | $4.95 | $60K | 24,390 |
| 2019-01-14 | LOSORDO DOUGLAS W See Remarks | Grant or award | +16,000 | 113,753 | ||
| 2019-01-14 | LOSORDO DOUGLAS W See Remarks | Shares withheld for taxes | −2,159 | 111,594 | ||
| 2019-01-14 | LOSORDO DOUGLAS W See Remarks | Grant or award · Stock Options (Right to Buy) | +24,000 | 24,000 | ||
| 2019-01-14 | Talamo Joseph SVP and CFO | Grant or award | +16,000 | 49,415 | ||
| 2019-01-14 | Talamo Joseph SVP and CFO | Shares withheld for taxes | −2,159 | 47,256 | ||
| 2019-01-14 | Talamo Joseph SVP and CFO | Grant or award · Stock Options (Right to Buy) | +24,000 | 24,000 | ||
| 2019-01-14 | BROWN GREGORY B Director | Grant or award | +12,121 | $4.95 | $60K | 27,583 |
| 2019-01-14 | Mazzo David J Chief Executive Officer | Grant or award | +47,000 | 157,706 | ||
| 2019-01-14 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −6,301 | 151,405 | ||
| 2019-01-14 | Mazzo David J Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +71,000 | 71,000 | ||
| 2019-01-14 | TRABER PETER G Director | Grant or award | +12,121 | $4.95 | $60K | 27,733 |
| 2019-01-14 | KLOSK STEVEN M Director | Grant or award | +12,121 | $4.95 | $60K | 29,933 |
| 2019-01-14 | MYERS STEVEN S Director | Grant or award | +12,121 | $4.95 | $60K | 57,027 |
| 2019-01-08 | LOSORDO DOUGLAS W See Remarks | Shares withheld for taxes | −1,795 | $4.64 | $8K | 97,753 |
| 2019-01-08 | Talamo Joseph SVP and CFO | Shares withheld for taxes | −1,795 | $4.64 | $8K | 33,415 |
Page 9 of 18 · 345 trades